Althobaiti Faisal, Alkhatib Ahmad, Alharbi Naif, Alwadai Mohammed, Alqarni Ali, Allebdi Khalid
Neurology, King Fahad General Hospital, Jeddah, SAU.
Medicine and Surgery, University of Jeddah, Jeddah, SAU.
Cureus. 2024 Feb 23;16(2):e54788. doi: 10.7759/cureus.54788. eCollection 2024 Feb.
Stroke is a predominant contributor to global mortality and disability and represents a complex and heterogeneous disease characterized by diverse risk factors and clinical presentations. The likelihood of stroke patients being at risk of a second stroke within the first five years is higher, especially within the initial two weeks. The distressing prospect of experiencing recurrent stroke shortly after reperfusion therapy adds an additional layer of complexity, potentially reversing prior progress. In the present case, we describe a patient who experienced a recurrent stroke within 24 hours, affecting the contralateral middle cerebral artery (MCA). This recurrence occurred after the individual underwent thrombolysis therapy for the initial stroke, emphasizing the intricate challenges associated with managing such cases and the imperative for targeted interventions to mitigate further risks and enhance patient outcomes.
中风是全球死亡率和残疾率的主要促成因素,是一种复杂的异质性疾病,具有多种风险因素和临床表现。中风患者在头五年内发生二次中风的风险较高,尤其是在最初两周内。再灌注治疗后不久就经历复发性中风的令人痛苦的前景增加了额外的复杂性,可能会逆转之前的进展。在本病例中,我们描述了一名在24小时内发生复发性中风的患者,累及对侧大脑中动脉(MCA)。这种复发发生在该患者因初次中风接受溶栓治疗之后,强调了处理此类病例所面临的复杂挑战,以及采取有针对性干预措施以降低进一步风险和改善患者预后的紧迫性。